Stanley Black & Decker, Inc. vs State Street SPDR S&P Biotech ETF — how do they compare? Stanley Black & Decker, Inc. trades at $87.62 (market cap $13.60B), while State Street SPDR S&P Biotech ETF trades at $154.5. The key difference: Stanley Black & Decker, Inc. pays a 3.79% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.
| SWK | XBI | |
|---|---|---|
Market Cap | $13.60B | — |
52-Week High | $94.12 | $164.28 |
52-Week Low | $62.12 | $85.16 |
Enterprise Value | $19.77B | — |
Dividend Yield | 3.79% | — |
Sector | — | Broad Market / Factor |
Trailing returns across standard periods
Latest headlines on both assets
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.
Read more on SWK →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →